US1710774076 - CDXC - A2AG5N (XNCM)
CHROMADEX CORP Action
5,56 USD
Cours actuels de CHROMADEX CORP
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière | Variation journalière % |
---|---|---|---|---|---|---|
NASDAQ |
CDXC
|
USD
|
24.12.2024 21:59
|
5,56 USD
| 5,30 USD | 4,91 % |
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
0,00 % | -2,46 % | -25,27 % | 47,09 % | 118,04 % | 283,45 % | 28,11 % |
Profil de l'entreprise pour CHROMADEX CORP Action
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Données de l'entreprise pour CHROMADEX CORP Action
Nom CHROMADEX CORP
Société ChromaDex Corporation
Symbole CDXC
Site web https://www.chromadex.com
Marché d'origine
NASDAQ CAPITAL MARKET
WKN A2AG5N
ISIN US1710774076
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Robert N. Fried
Capitalisation boursière 276 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 10900 Wilshire Boulevard, 90024 Los Angeles
Date d'introduction en bourse 2008-06-25
Fractionnements d'actions
Date | Fractionnement |
---|---|
13.04.2016 | 1:3 |
Symboles boursiers
Nom | Symbole |
---|---|
Frankfurt | OCD1.F |
NASDAQ | CDXC |
Autres actions
Les investisseurs qui détiennent CHROMADEX CORP ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.